Home > Products > CD3 & CD79B
> Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (VHH-IgG)
Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (VHH-IgG) (CAT#: BSSG-371)
Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (VHH-IgG) is formed by an IgG and two VHH fragments. The VHHs from an anti-CD79B antibody variable domain are respectively connected to the N terminus of the anti-CD3 IgG heavy chains or light chains to form VHH-(H)IgG or VHH-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Chronic lymphocytic leukemia (CLL); Non-Hodgkin's lymphoma (NHL); Diffuse large B cell lymphoma (DLBCL) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (VHH-IgG) (BSSG-371). Click the button below to contact us or submit your feedback about this product.